|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Products, net | |||||
| Collaboration and other | |||||
| Total revenues | |||||
| Cost and expenses: | |||||
| Cost of sales (excluding amortization of in-licensed rights) | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Settlement and license charges | |||||
| Restructuring charge | |||||
| Amortization of in-licensed rights | |||||
| Total cost and expenses | |||||
| Operating (loss) income | |||||
| Other (loss) income, net: | |||||
| Other (expense) income, net | |||||
| Gain (loss) on debt extinguishment | |||||
| Gain (loss) on contingent consideration, net* | |||||
| Gain from sale of Priority Review Voucher | |||||
| Total other (loss) income, net | |||||
| (Loss) income before income tax expense | |||||
| Income tax expense | |||||
| Net (loss) income | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gains (losses) on investments, net of tax | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive (loss) income | |||||
| (Loss) earnings per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average number of shares of common stock used in computing (loss) earnings per share: | |||||
| Basic | |||||
| Diluted | |||||
Loading...